World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
74
Citations
18647
World Ranking
5622
National Ranking
405

Thomas Tüting publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Thomas Tüting sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 227 publications — 60th percentile

60% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Thomas Tüting D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas Tüting sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 74 D-Index — 72nd percentile

72% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Thomas Tüting is affiliated with Otto-von-Guericke University Magdeburg in Germany. Their research predominantly spans the fields of Medicine, Biochemistry, Genetics and Molecular Biology, as well as Immunology and Microbiology. The primary subfields of study include Oncology, Immunology, Molecular Biology, Genetics, and Dermatology.

The main topics covered in Thomas Tüting's work focus on several critical areas within cancer and immunology research:

  • Cutaneous Melanoma Detection and Management
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Melanoma and MAPK Pathways
  • CAR-T Cell Therapy Research
  • Immune Cell Function and Interaction
  • CRISPR and Genetic Engineering

Among recent publications, the following papers demonstrate areas of active research:

  • "CD4+ T Cell-Induced Inflammatory Cell Death Controls Immune-Evasive Tumours," 2023, published in Nature
  • "Prognosis of Patients With Primary Melanoma Stage I and II According to American Joint Committee on Cancer Version 8 Validated in Two Independent Cohorts: Implications for Adjuvant Treatment," 2022, Journal of Clinical Oncology
  • "Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma," 2020, Immunity
  • "Prognosis of Patients With Stage III Melanoma According to American Joint Committee on Cancer Version 8: A Reassessment on the Basis of 3 Independent Stage III Melanoma Cohorts," 2020, Journal of Clinical Oncology
  • "N-glycosylation Regulates Intrinsic IFN-γ Resistance in Colorectal Cancer: Implications for Immunotherapy," 2022, Gastroenterology

Frequent collaboration characterizes Thomas Tüting's research activities. The most common co-authors include:

  • Miriam Mengoni
  • Evelyn Gaffal
  • Andreas Braun
  • Dirk Schadendorf
  • Christoffer Gebhardt

The venues where Thomas Tüting regularly publishes involve specialized journals that reflect the focus on dermatology, oncology, and cancer research:

  • JDDG Journal der Deutschen Dermatologischen Gesellschaft
  • European Journal of Cancer
  • Cancer Research
  • Nature
  • Journal of Clinical Oncology

Best Publications

  • Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy

    Antonella Sistigu;Takahiro Yamazaki;Erika Vacchelli;Kariman Chaba

  • Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma

    Tobias Bald;Thomas Quast;Jennifer Landsberg;Meri Rogava

  • Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation

    Jennifer Landsberg;Judith Kohlmeyer;Marcel Renn;Tobias Bald

  • A comparison of two types of dendritic cell as adjuvants for the induction of melanoma-specific T-cell responses in humans following intranodal injection.

    Helmut Jonuleit;Andrea Giesecke‐Tuettenberg;Thomas Tüting;Beatrice Thurner‐Schuler

  • 5′-triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma

    Poeck H;Besch R;Maihoefer C;Maihoefer C;Renn M

  • Oxidative Damage of DNA Confers Resistance to Cytosolic Nuclease TREX1 Degradation and Potentiates STING-Dependent Immune Sensing

    Nadine Gehrke;Christina Mertens;Thomas Zillinger;Jörg Wenzel

  • Attenuation of allergic contact dermatitis through the endocannabinoid system

    Meliha Karsak;Evelyn Gaffal;Rahul Date;Lihua Wang-Eckhardt

  • The experimental power of FR900359 to study Gq-regulated biological processes

    Ramona Schrage;Anna Lena Schmitz;Evelyn Gaffal;Suvi Annala

  • Diagnostic Performance of Whole Body Dual Modality 18F-FDG PET/CT Imaging for N- and M-Staging of Malignant Melanoma: Experience With 250 Consecutive Patients

    Michael J. Reinhardt;Alexius Y. Joe;Ursula Jaeger;Andrea Huber

  • Tissue-resident memory CD8 + T cells promote melanoma-immune equilibrium in skin

    Simone L Park;Anthony Buzzai;Jai Rautela;Jyh Liang Hor

  • Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.

    Philipp Koch;Peter Breuer;Michael Peitz;Johannes Jungverdorben

  • Depletion of CD25(+) CD4(+) T cells and treatment with tyrosinase-related protein 2-transduced dendritic cells enhance the interferon alpha-induced, CD8(+) T-cell-dependent immune defense of B16 melanoma.

    Julia Steitz;Jürgen Brück;Julia Lenz;Jürgen Knop

  • Autologous Human Monocyte-Derived Dendritic Cells Genetically Modified to Express Melanoma Antigens Elicit Primary Cytotoxic T Cell Responses In Vitro: Enhancement by Cotransfection of Genes Encoding the Th1-Biasing Cytokines IL-12 and IFN-α

    Thomas Tüting;Cara C. Wilson;Dina M. Martin;Yvette L. Kasamon

  • Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?

    Michael Hölzel;Anton Bovier;Thomas Tüting

  • Immune Cell–Poor Melanomas Benefit from PD-1 Blockade after Targeted Type I IFN Activation

    Tobias Bald;Jennifer Landsberg;Dorys Lopez-Ramos;Marcel Renn

  • Reactive Neutrophil Responses Dependent on the Receptor Tyrosine Kinase c-MET Limit Cancer Immunotherapy.

    Nicole Glodde;Nicole Glodde;Tobias Bald;Tobias Bald;Tobias Bald;Debby van den Boorn-Konijnenberg;Kyohei Nakamura

  • Enhanced type I interferon signalling promotes Th1‐biased inflammation in cutaneous lupus erythematosus

    Joerg Wenzel;Eva Wörenkämper;Silke Freutel;Stefanie Henze

  • Effective collaboration between marginal metallophilic macrophages and CD8+ dendritic cells in the generation of cytotoxic T cells

    Ronald Backer;Timo Schwandt;Mascha Greuter;Marije Oosting

  • Targeted Activation of Innate Immunity for Therapeutic Induction of Autophagy and Apoptosis in Melanoma Cells

    Damià Tormo;Agnieszka Chęcińska;Direna Alonso-Curbelo;Eva Pérez-Guijarro

  • Attenuation of allergic contact dermatitis through the endocannabinoid system.

    Meliha Karsak;Evelyn Gaffal;Wang-Eckhardt, Lihua Date, Rahul;Petrosino, Stefania Rehnelt, Jennifer

Frequent Co-Authors

Walter J. Storkus
Walter J. Storkus University of Pittsburgh
Michael T. Lotze
Michael T. Lotze University of Pittsburgh
Jürgen Knop
Jürgen Knop Johannes Gutenberg University of Mainz
Richard A. Scolyer
Richard A. Scolyer Royal Prince Alfred Hospital
Andrea Gambotto
Andrea Gambotto University of Pittsburgh
Alexander Enk
Alexander Enk Heidelberg University
Gunther Hartmann
Gunther Hartmann University Hospital Bonn
Mark J. Smyth
Mark J. Smyth QIMR Berghofer Medical Research Institute
Jochen Utikal
Jochen Utikal German Cancer Research Center
Veit Hornung
Veit Hornung Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Thomas Tüting

Trending Scientists

Recently Published Articles